February 2021

MIND diet associated with cardiac, cognitive benefits | 'I have so much hope now' | FDA's lamotrigine warning ()
February in Review: COVID-19 vaccines | Heart damage & energy drinks | A new FDA recall | A big loss for cardiology ()
Week in Review: Too much coffee is bad for the heart | ACC.21 now 100% virtual | The keto diet & CVD | TMVR for HF ()
New data on the keto diet & CVD | How 64% of U.S. COVID-19 hospitalizations could have been avoided ()
New data on TMVR for HF patients after 3 years | Plant-based protein & CVD | Cardiologists much more unhappy now ()
Heart Failure: Coffee reduces the risk of heart failure | FDA approves expanded indication for sacubitril/valsartan ()
Too much coffee is bad for the heart | Female physicians associated with better outcomes | AMI care during the pandemic ()
Vascular & Endovascular: Statins effective in older stroke patients | New data on stroke mortality among men & women ()
Heart Rhythm: AI predicts AFib | How the iPhone 12 can put patients at risk | FDA announces an urgent recall ()
ACC.21 now completely virtual | MRIs appear safe if patient has a cardiac device with abandoned leads ()
Breaking News: ACC.21 goes completely virtual ()
What older patients get wrong about statins & aspirin | Women have lower ‘normal’ BP range than men | Metformin & COVID-19 ()
Economics & Policy: Should the FDA address potential heart damage from energy drinks? | Casana raises $14M ()
The Week in Review: Compensation in cardiology | Groundbreaking cardiologist dies | Shockwave's new FDA approval ()
Heart damage present in 54% of COVID-19 patients after discharge | Intelerad acquires Lumedx | AI predicts AFib ()
Breaking News: Intelerad Medical Systems acquires Lumedx ()
Prevention & Risk Reduction: The latest metformin recall | Weight loss & a vegan diet | Marijuana use & blood pressure ()
Bernard Lown, groundbreaking cardiologist, dies at 99 | FDA approves expanded indication for sacubitril/valsartan ()
Practice Management: COVID-driven changes to patient care | Key data on vitamin D & calcium supplements | Burnout ()
Value-based care & compensation | Shockwave’s IVL tech gains new FDA approval | Vaccination for high-risk patients ()
Breaking News: Shockwave’s IVL technology gains FDA approval for treating advanced coronary artery disease ()
COVID-19's lasting impact on patient care | Ablation shows potential for treating HF patients with AFib ()
The Week in Review: iPhone 12 deactivates ICDs | Marijuana use & blood pressure | A look at the future? | AI & AFib ()
Interventional & Surgery: ‘Encouraging’ 5-year data on RESILIA tissue aortic valve | PCI & subclinical hypothyroidism ()
Apple Watch IDs COVID-19 | Energy drinks may damage the heart | AI improves AFib detection ()
High blood pressure & AFib | Statins still effective when treating older stroke patients ()
Acute Coronary Syndromes: Reducing all-cause mortality for MI patients | Hospitalization rates for chest pain ()
Coffee reduces heart failure risk—but not if it’s decaf | A new design for mechanical heart valves | CCTA guidelines ()
Marijuana use benefits older adults with hypertension | STEMI patients with cancer | COVID-19 & bioprosthetic valve thrombosis ()
COVID-19: New data on cardiac arrest | CDC's warning for healthcare workers getting a vaccine | Burnout & the pandemic ()
Apple iPhone capable of deactivating ICDs | Battle of the diets: Vegan vs. Mediterranean | COVID-19 & cardiac arrest ()
Best of the Week: Key info for healthcare workers receiving a COVID-19 vaccine | 2 new recalls | Sacubitril/valsartan for HFpEF ()
Boston Scientific recalls S-ICD part after multiple injuries, 1 death | How green tea or coffee can help stroke, MI survivors ()
Structural Heart Disease: Out-of-hospital mortality & TAVR | Expanded coverage for TEER | TAVR & COVID-19 ()
Death & CV events among hospitalized COVID-19 patients | Casana raises $14M | 'Concerning' TAVR data ()
Key takeaways from the latest valvular heart disease guidelines | USPSTF rules on carotid artery stenosis screening ()
Imaging & Physiology: AI that IDs high-risk patients | Know your options when treating low-risk stable chest pain ()
A new warning for healthcare workers receiving a COVID-19 vaccine | Sacubitril/valsartan for HFpEF patients ()